Yasmin Post Marketing Surveillance
NCT00923572 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 777
Last updated 2015-11-11
Summary
The objective of this Post Marketing Surveillance (PMS) is to gain information about safety and efficacy in real practice.
Conditions
- Contraception
Interventions
- DRUG
-
EE30/DRSP (Yasmin, BAY86-5131)
Patients in daily life clinical practice treatment receiving Yasmin according to indication on the label.
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bayer Study Director · Bayer
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-12-31
- Primary Completion
- 2013-05-31
- Completion
- 2013-08-31
Countries
- South Korea
More Related Trials
-
Post Marketing Surveillance Study For Sayana®
NCT02104557 ·Status: COMPLETED
-
Efficacy and Safety of Two Flexible Extended Regimens of BAY86-5300 (SH T00186D) in Comparison With the Conventional Regimen of YAZ
NCT00567164 ·Status: COMPLETED ·Phase: PHASE3
-
YAZ Post-marketing Surveillance in Japan
NCT01375998 ·Status: COMPLETED
-
Efficacy and Safety Oral Contraceptive Study
NCT00185484 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Counseling on the Continuation Rates and Compliance for Newly Prescribed Oral Contraceptives (Yasmin® or Any Other Oral Contraceptives (OC)
NCT00905684 ·Status: COMPLETED
-
Study to Investigate Compliance With the Oral Contraceptive SH T00186D in a Flexible Extended Regimen Supported by a Dispenser With a Reminder Function
NCT01257984 ·Status: COMPLETED ·Phase: PHASE3
-
To Investigate Efficacy of YAZ in the Treatment of Dysmenorrhea
NCT02617537 ·Status: WITHDRAWN ·Phase: PHASE3
-
Investigate Impact of Yasmin vs Microgynon on Hemostasis Parameters in Healthy Women
NCT00651846 ·Status: COMPLETED ·Phase: PHASE4
-
Investigation of Bioequivalence of Ethinylestradiol (EE) and Drospirenone (DRSP) in Two Different Tablet Formulations: Yasmin and Yasmin + Levomefolate Calcium (Metafolin) & L-5-MTHF in Two Different Tablet Formulations: Levomefolate Calcium (Metafolin) and Yasmin + Levomefolate Calcium (Metafolin)
NCT01253174 ·Status: COMPLETED ·Phase: PHASE1
-
LCS12 vs Combined Oral Contraceptive (COC) User Satisfaction Study
NCT01254292 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of CDB-2914 for Emergency Contraception
NCT00411684 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of CDB-2914 in Comparison to Levonorgestrel for Emergency Contraception
NCT00551616 ·Status: COMPLETED ·Phase: PHASE3
-
Open-Label Study to Evaluate the Safety and Efficacy of a Low-Dose 28-Day Oral Contraceptive
NCT00362479 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy Trial of CDB 2914 for Emergency Contraception
NCT00271583 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
YAZ Premenstrual Dysphoric Disorder (PMDD) in China
NCT00824187 ·Status: COMPLETED ·Phase: PHASE3
-
YAZ, Oral Contraceptive Registration in China
NCT00819312 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Study on Yasmin® vs. Marvelon® in Chinese Women Requiring Contraception
NCT00185419 ·Status: COMPLETED ·Phase: PHASE3
-
Drospirenone (3 mg) + Ethinyl Estradiol (0.03 mg) Tablets Relative to Yasmin®
NCT06233058 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Endometrial Safety Study
NCT00522873 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Investigate Efficacy and Safety of a New Oral Contraceptive
NCT00185289 ·Status: COMPLETED ·Phase: PHASE3
-
Oral Contraceptives as Infertility Treatments for Premature Ovarian Failure
NCT02757469 ·Status: UNKNOWN ·Phase: NA
-
Study of Combined Oral Contraceptive Effects in Female Subjects
NCT02157467 ·Status: COMPLETED ·Phase: PHASE1
-
Qlaira rPMS (Regulatory Post Marketing Surveillance) Study in Korea
NCT01797809 ·Status: COMPLETED
-
Efficacy and Safety Study for an Oral Contraceptive Containing Folate
NCT00468481 ·Status: COMPLETED ·Phase: PHASE3
-
Study on Safety and Efficacy of an Oral Contraceptive in Long Cycles
NCT00266032 ·Status: COMPLETED ·Phase: PHASE3